应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。
关闭
RFAI RF Acquisition Corp II
休市中 02-20 16:00:00 EST
10.85
+0.00
0.00%
最高
10.85
最低
10.85
成交量
0.00
今开
10.85
昨收
10.85
日振幅
0.00%
总市值
9,053万
流通市值
3,728万
总股本
834.38万
成交额
0.00
换手率
0.00%
流通股本
343.57万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
资讯
新帖
简况
AI药物发现先锋企业南洋生物制药有限公司与RF Acquisition Corp II达成15亿美元业务合并协议，寻求公开上市
美股速递 · 2025-10-02
AI药物发现先锋企业南洋生物制药有限公司与RF Acquisition Corp II达成15亿美元业务合并协议，寻求公开上市
RF Acquisition Corp II - 交易完成后，合并后的公司预计将在纳斯达克上市，股票代码为"Nyb"
美股速递 · 2025-10-02
RF Acquisition Corp II - 交易完成后，合并后的公司预计将在纳斯达克上市，股票代码为"Nyb"
加载更多
公司概况
公司名称：
RF Acquisition Corp II
所属市场：
NASDAQ
上市日期：
--
主营业务：
RF Acquisition Corp II是一家空白支票公司，于2024年2月5日注册成立，为开曼群岛豁免公司，目的是与一个或多个企业或实体进行合并、股份交换、资产收购、股份购买、重组或类似业务合并。
发行价格：
--
{"stockData":{"symbol":"RFAI","market":"US","secType":"STK","nameCN":"RF Acquisition Corp II","latestPrice":10.85,"timestamp":1771621200000,"preClose":10.85,"halted":0,"volume":0,"delay":0,"changeRate":0,"floatShares":3435700,"shares":8343800,"eps":0.237907,"marketStatus":"休市中","change":0,"latestTime":"02-20 16:00:00 EST","open":10.85,"high":10.85,"low":10.85,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":0.237907,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1771837200000},"marketStatusCode":7,"adr":0,"exchange":"NASDAQ","adjPreClose":10.85,"volumeRatio":0},"requestUrl":"/m/hq/s/RFAI","defaultTab":"news","newsList":[{"id":"1125614793","title":"AI药物发现先锋企业南洋生物制药有限公司与RF Acquisition Corp II达成15亿美元业务合并协议，寻求公开上市","url":"https://stock-news.laohu8.com/highlight/detail?id=1125614793","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1125614793?lang=zh_cn&edition=full","pubTime":"2025-10-02 19:51","pubTimestamp":1759405878,"startTime":"0","endTime":"0","summary":"人工智能药物发现领域的先锋企业南洋生物制药有限公司(Nanyang Biologics Pte. Ltd.)宣布，已与RF Acquisition Corp II签署业务合并协议。这项交易总价值达15亿美元，旨在推进公司的公开上市计划。\n通过此次合并协议，南洋生物制药将借助RF Acquisition Corp II的平台实现公开上市目标。该交易标志着这家专注于AI驱动药物研发的创新企业迈出了资本市场化的重要一步。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RFAI"],"gpt_icon":0},{"id":"1163733194","title":"RF Acquisition Corp II - 交易完成后，合并后的公司预计将在纳斯达克上市，股票代码为\"Nyb\"","url":"https://stock-news.laohu8.com/highlight/detail?id=1163733194","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1163733194?lang=zh_cn&edition=full","pubTime":"2025-10-02 19:12","pubTimestamp":1759403554,"startTime":"0","endTime":"0","summary":"RF Acquisition Corp II - 交易完成后，合并后的公司预计将在纳斯达克上市，股票代码为\"Nyb\"","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RFAI"],"gpt_icon":0}],"profile":{"stockEarnings":[{"period":"1week","weight":0.0046},{"period":"1month","weight":0.0056},{"period":"3month","weight":0.0074},{"period":"6month","weight":0.0226},{"period":"1year","weight":0.0514},{"period":"ytd","weight":0.0093}],"compareEarnings":[{"period":"1week","weight":0.0113},{"period":"1month","weight":0.0059},{"period":"3month","weight":0.0461},{"period":"6month","weight":0.0684},{"period":"1year","weight":0.1295},{"period":"ytd","weight":0.011}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"RF Acquisition Corp II是一家空白支票公司，于2024年2月5日注册成立，为开曼群岛豁免公司，目的是与一个或多个企业或实体进行合并、股份交换、资产收购、股份购买、重组或类似业务合并。","exchange":"NASDAQ","name":"RF Acquisition Corp II","nameEN":"RF Acquisition Corp II"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"RF Acquisition Corp II(RFAI)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供RF Acquisition Corp II(RFAI)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"RF Acquisition Corp II,RFAI,RF Acquisition Corp II股票,RF Acquisition Corp II股票老虎,RF Acquisition Corp II股票老虎国际,RF Acquisition Corp II行情,RF Acquisition Corp II股票行情,RF Acquisition Corp II股价,RF Acquisition Corp II股市,RF Acquisition Corp II股票价格,RF Acquisition Corp II股票交易,RF Acquisition Corp II股票购买,RF Acquisition Corp II股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"RF Acquisition Corp II(RFAI)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供RF Acquisition Corp II(RFAI)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}